MTOR and thyroid cancer: Moreover, the malignant phenotypes induced by AURKA overexpression were partly blocked by AKT inhibitors and mTOR inhibitors, indicating that the oncogenic role of AURKA in thyroid cancer cells partly depends on the PI3K/AKT signalling pathway.